Trademark Attorney / Law Firm
James Valbrun – Trademark Portfolio
James Valbrun specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 8 of 10 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 3 other Nice Classification classes. Filing activity spans from 2014 to 2023. Currently, 4 trademarks are registered and 1 is pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James Valbrun's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademark applications has James Valbrun filed?
James Valbrun has filed 10 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 4 registered, 1 pending, 2 abandoned, 3 cancelled.
What trademark classes does James Valbrun specialize in?
James Valbrun has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 35 (Advertising & Business), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
How long has James Valbrun been filing trademarks?
James Valbrun's trademark filing history with the USPTO spans from 2014 to 2023, covering 9 years of trademark practice. During this period, James Valbrun has handled 10 trademark applications.
What is James Valbrun's trademark registration success rate?
James Valbrun has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.